Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

Related Articles by Review for PubMed (Select 11162945)

1.
2.

The prevention of breast cancer through reduced ovarian steroid exposure.

Spicer DV, Pike MC.

Acta Oncol. 1992;31(2):167-74. Review.

PMID:
1622631
3.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770
4.

Sex steroids and breast cancer prevention.

Spicer DV, Pike MC.

J Natl Cancer Inst Monogr. 1994;(16):139-47. Review.

PMID:
7999456
6.

Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement.

Nason FG, Nelson BE.

Obstet Gynecol Clin North Am. 1994 Jun;21(2):245-70. Review.

PMID:
7936544
7.

Cancer risk in women receiving estrogen-progestin replacement therapy.

Persson I.

Maturitas. 1996 May;23 Suppl:S37-45. Review.

PMID:
8865138
8.

Links between hormone replacement therapy and neoplasia.

Hulka BS.

Fertil Steril. 1994 Dec;62(6 Suppl 2):168S-175S. Review.

PMID:
7958013
9.

Reproductive factors and breast cancer.

Kelsey JL, Gammon MD, John EM.

Epidemiol Rev. 1993;15(1):36-47. Review.

PMID:
8405211
10.

Do hormones cause breast cancer?

Thomas DB.

Cancer. 1984 Feb 1;53(3 Suppl):595-604. Review.

PMID:
6362820
11.

Effect of endogenous and exogenous hormones on breast cancer: epidemiology.

Vessey MP.

Verh Dtsch Ges Pathol. 1997;81:493-501. Review.

PMID:
9474890
12.

Use of HRT and the subsequent risk of cancer.

Beral V, Banks E, Reeves G, Appleby P.

J Epidemiol Biostat. 1999;4(3):191-210; discussion 210-5. Review.

PMID:
10695959
13.

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.

Pike MC, Spicer DV, Dahmoush L, Press MF.

Epidemiol Rev. 1993;15(1):17-35. Review.

PMID:
8405201
14.

The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.

Bernstein L.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):288-96. Review.

PMID:
16611204
15.

Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies.

Eliassen AH, Hankinson SE.

Adv Exp Med Biol. 2008;630:148-65. Review.

PMID:
18637490
16.

Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.

Kelsey JL, Whittemore AS.

Ann Epidemiol. 1994 Mar;4(2):89-95. Review.

PMID:
8205289
17.

Hormones and cancer in humans.

Key TJ.

Mutat Res. 1995 Dec;333(1-2):59-67. Review.

PMID:
8538637
18.

Menopause, hormone replacement therapy and cancer.

La Vecchia C, Brinton LA, McTiernan A.

Maturitas. 2001 Aug 25;39(2):97-115. Review.

PMID:
11514109
19.

Epidemiologic analysis of breast and gynecologic cancers.

Hulka BS.

Prog Clin Biol Res. 1997;396:17-29. Review.

PMID:
9108587
20.

[Epidemiologic considerations on the significance of hormones in carcinogenesis].

Obermair A, Jirecek S, Leodolter S.

Gynakol Geburtshilfliche Rundsch. 1998;38(2):73-9. Review. German.

PMID:
9815521
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk